Skip to main content

Table 2 Mean back fat levels at the different time points in the different parity and treatment groups (with P = peforelin, E = eCG, C = control and BF1 = back fat measured one month after insemination; BF2 = back fat measured at farrowing; BF3 = back fat measured at weaning; BF3-BF2 = calculated back fat loss during lactation and SD = standard deviation) in 212 sows in three herds

From: Effect of a GnRH analogue (peforelin) on the litter performance of gilts and sows

 

Group

n

BF1 ± SD (mm)

BF2 ± SD (mm)

BF3 ± SD (mm)

BF3-BF2 ± SD (mm)

Gilts

P

28

16.5 ± 3.5

21.0 ± 4.2

17.5 ± 4.2

−3.3 ± 2.6

E

17

17.7 ± 2.1

22.9 ± 3.5

18.9 ± 2.8

−3.6 ± 3.2

C

25

17.9 ± 2.5

22.3 ± 3.8

19.1 ± 3.7

−3.4 ± 3.4

Primiparous

P

30

19.0 ± 3.3

21.9 ± 5.6

18.6 ± 4.5

−4.6 ± 3.3

E

15

16.5 ± 3.4

20.7 ± 3.1

16.5 ± 3.9

−4.2 ± 2.1

C

24

17.6 ± 3.4

20.6 ± 3.3

16.7 ± 3.4

−3.4 ± 3.3

Pluriparous

P

20

16.2 ± 4.1b

21.2 ± 6.1

16.4 ± 3.2

−4.0 ± 2.9

E

27

19.7 ± 4.6a

24.1 ± 4.7

19.1 ± 4.5

−3.3 ± 4.2

C

26

17.8 ± 3.8a,b

21.0 ± 4.2

17.8 ± 3.6

−4.3 ± 3.6

All parities

P

78

18.4 ± 3.6

22.2 ± 4.5

18.1 ± 4.0

−4.0 ± 3.0

E

59

17.5 ± 3.5

21.8 ± 4.3

18.3 ± 4.0

−3.4 ± 3.7

C

75

17.2 ± 3.6

21.3 ± 4.8

17.4 ± 3.7

−4.0 ± 3.1

  1. a, b: Within a specific parity group, differences among treatment groups were statistically significant (p ≤ 0.05)